Disco.I think some very silly institution sold down to $3.22.The report from acrux /eli lilly presentation re axiron sales was very encouraging.The figures were up to the 10th of june 2011,if you extrapolate the figures up to 4th july one would estimate that axiron has potentially up to 40% of the specialist new scrip market and 20% of the primary doctors market.I have heard that eli lilly is still ramping up their sales reps so one would have to say it has been a fantastic launch of axiron.
Add to My Watchlist
What is My Watchlist?
